Top 4 NASDAQ Stocks In The Drugs Generic Industry With The Highest EPS Growth Forecast For Next 5 Years

Below are the top drugs generic stocks on the NASDAQ in terms of EPS growth forecast for the next five years. Sagent Pharmaceuticals, Inc. SGNT earnings per share growth forecast for the next five years is 70.00%. Sagent Pharmaceuticals' PEG ratio is 0.88. Evoke Pharma, Inc. EVOK EPS growth forecast for the next five years is 40.00%. Evoke Pharma's trailing-twelve-month EPS is -$1.98. Akorn, Inc. AKRX EPS growth forecast for the next five years is 33.15%. Akorn's trailing-twelve-month profit margin is 5.10%. Avanir Pharmaceuticals, Inc. AVNR earnings per share growth forecast for the next five years is 19.20%. Avanir Pharmaceuticals' trailing-twelve-month revenue is $115 million.